Translational Development Acquisition (TDACW) Net Income towards Common Stockholders (QoQ) (2024 - 2026)
Translational Development Acquisition (TDACW) Net Income towards Common Stockholders (QoQ) (2024 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Centurion Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 312.16 Mn | 312.16 Mn | - |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - |
| 5 | Churchill Capital Corp IX | 310.50 Mn | 310.50 Mn | - |
| 6 | WEN Acquisition | 308.55 Mn | 308.55 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 304.08 Mn | 304.08 Mn | - |
| 8 | Bold Eagle Acquisition | 274.25 Mn | 274.25 Mn | - |
| 9 | Soulpower Acquisition | 265.04 Mn | 265.04 Mn | - |
| 10 | Translational Development Acquisition | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.80% |
| Dec 31, 2025 | -283.64% |
| Sep 30, 2025 | 278.76% |
| Jun 30, 2025 | -70.45% |
| Mar 31, 2025 | 1,904.45% |
| Dec 31, 2024 | 195.07% |
| Sep 30, 2024 | -3,536.97% |